Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 130, Issue 19
November 9 2017
Issue Cover

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Recombinant ADAMTS-13: goodbye, allergic reactions!
Clinical Trials & Observations
Ravi Sarode
View Articletitled, Recombinant ADAMTS-13: goodbye, allergic reactions!
INSIDE BLOOD COMMENTARY
Prognostic relevance of CCAs/Ph− in CML settled
Rüdiger Hehlmann
View Articletitled, Prognostic relevance of CCAs/Ph<sup>−</sup> in CML settled
INSIDE BLOOD COMMENTARY
’Tis one thing to adhere, another to migrate
Christopher J. Kuckleburg
View Articletitled, ’Tis one thing to adhere, another to migrate
INSIDE BLOOD COMMENTARY
Releasing the FKBP12 brake on hepcidin
Nermi L. Parrow,Robert E. Fleming
View Articletitled, Releasing the FKBP12 brake on hepcidin
INSIDE BLOOD COMMENTARY
FcγR and SCD alloimmunization: a nonclass(ical) act
Karina Yazdanbakhsh
View Articletitled, FcγR and SCD alloimmunization: a nonclass(ical) act
INSIDE BLOOD COMMENTARY
Notching up B-cell pathology in chronic GVHD
Vedran Radojcic,Leo Luznik
View Articletitled, Notching up B-cell pathology in chronic GVHD

PLENARY PAPER

CLINICAL TRIALS AND OBSERVATIONS
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura
Clinical Trials & Observations
Marie Scully,Paul Knöbl,Karim Kentouche,Lawrence Rice,Jerzy Windyga,Reinhard Schneppenheim,Johanna A. Kremer Hovinga,Michiko Kajiwara,Yoshihiro Fujimura,Caterina Maggiore,Jennifer Doralt,Christopher Hibbard,Leah Martell,Bruce Ewenstein
View Articletitled, Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura
Supplemental data

REVIEW ARTICLE

Philadelphia chromosome–like acute lymphoblastic leukemia
Clinical Trials & Observations
Sarah K. Tasian,Mignon L. Loh,Stephen P. Hunger
View Articletitled, Philadelphia chromosome–like acute lymphoblastic leukemia

LYMPHOID NEOPLASIA

Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients
Benoit M. Cyrenne,Julia M. Lewis,Jason G. Weed,Kacie R. Carlson,Fatima N. Mirza,Francine M. Foss,Michael Girardi
View Articletitled, Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients
Supplemental data

MYELOID NEOPLASIA

Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment
Clinical Trials & Observations
Ghayas C. Issa,Hagop M. Kantarjian,Graciela Nogueras Gonzalez,Gautam Borthakur,Guilin Tang,William Wierda,Koji Sasaki,Nicholas J. Short,Farhad Ravandi,Tapan Kadia,Keyur Patel,Raja Luthra,Alessandra Ferrajoli,Guillermo Garcia-Manero,Mary Beth Rios,Sara Dellasala,Elias Jabbour,Jorge E. Cortes
View Articletitled, Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment
Supplemental data

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation
Ming Bai,Ricardo Grieshaber-Bouyer,Junxia Wang,Angela B. Schmider,Zachary S. Wilson,Liling Zeng,Olha Halyabar,Matthew D. Godin,Hung N. Nguyen,Anaïs Levescot,Pierre Cunin,Craig T. Lefort,Roy J. Soberman,Peter A. Nigrovic
View Articletitled, CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation
Supplemental data
Selectin catch-bonds mechanotransduce integrin activation and neutrophil arrest on inflamed endothelium under shear flow
Vasilios A. Morikis,Shannon Chase,Ted Wun,Elliot L. Chaikof,John L. Magnani,Scott I. Simon
View Articletitled, Selectin catch-bonds mechanotransduce integrin activation and neutrophil arrest on inflamed endothelium under shear flow
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes
Silvia Colucci,Alessia Pagani,Mariateresa Pettinato,Irene Artuso,Antonella Nai,Clara Camaschella,Laura Silvestri
View Articletitled, The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes
Supplemental data

TRANSFUSION MEDICINE

Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease
Sanne M. Meinderts,Joep W. R. Sins,Karin Fijnvandraat,Sietse Q. Nagelkerke,Judy Geissler,Michael W. Tanck,Christine Bruggeman,Bart J. Biemond,Anita W. Rijneveld,Jean-Louis H. Kerkhoffs,Sadaf Pakdaman,Anoosha Habibi,Robin van Bruggen,Taco W. Kuijpers,France Pirenne,Timo K. van den Berg
View Articletitled, Nonclassical <em>FCGR2C</em> haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease
Supplemental data

TRANSPLANTATION

An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD
Jonathan C. Poe,Wei Jia,Hsuan Su,Sarah Anand,Jeremy J. Rose,Prasanthi V. Tata,Amy N. Suthers,Corbin D. Jones,Pei Fen Kuan,Benjamin G. Vincent,Jonathan S. Serody,Mitchell E. Horwitz,Vincent T. Ho,Steven Z. Pavletic,Frances T. Hakim,Kouros Owzar,Dadong Zhang,Bruce R. Blazar,Christian W. Siebel,Nelson J. Chao,Ivan Maillard,Stefanie Sarantopoulos
View Articletitled, An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD
Supplemental data

LETTER TO BLOOD

Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL
Clinical Trials & Observations
Franco Locatelli,Maria Grazia Valsecchi,Anja Möricke,Martin Zimmermann,Bernd Gruhn,Andrea Biondi,Andreas E. Kulozik,Daniela Silvestri,Nicole Bodmer,Maria Caterina Putti,Stefan Burdach,Concetta Micalizzi,Andrea Teigler-Schlegel,Jörg Ritter,Andrea Pession,Gunnar Cario,Stefan Bielack,Giuseppe Basso,Thomas Klingebiel,Luciana Vinti,Carmelo Rizzari,Andishe Attarbaschi,Nicola Santoro,Rosanna Parasole,Georg Mann,Leonid Karawajew,Oskar A. Haas,Valentino Conter,Martin Schrappe
View Articletitled, Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL
Supplemental data

BLOOD WORK

Aleukemic mast cell leukemia associated with chronic myelomonocytic leukemia and chronic lymphocytic leukemia
Zhihong Hu,Sergej Konoplev
View Articletitled, Aleukemic mast cell leukemia associated with chronic myelomonocytic leukemia and chronic lymphocytic leukemia
Classical Hodgkin lymphoma arising in a patient with chronic lymphocytic leukemia (Richter syndrome)
Andrés E. Quesada,Sergej Konoplev
View Articletitled, Classical Hodgkin lymphoma arising in a patient with chronic lymphocytic leukemia (Richter syndrome)
All Issues

Advertisement intended for health care professionals

GM-CSF brings (good) memories
Interleukin-1 as a therapeutic target in TTP
Elevating TPO production up a Notch
Herpetic lymphadenitis mimicking Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma
Crespiatico I, Zaghi M, Mastini C, et al. First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. Blood. 2024;143(14):1399-1413.

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals